Electronic Updates for JTO Readers
The Diverse Diversity
MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma
Temsirolimus Inhibits Malignant Pleural Mesothelioma Growth In Vitro and In Vivo
Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy
Disparities in Lung Cancer Staging with Positron Emission Tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) Study
Routinely Obtained Diagnostic Material as a Source of RNA for Personalized Medicine in Lung Cancer Patients
Serial Measurements of Mesothelioma Serum Biomarkers in Asbestos-Exposed Individuals
Pleomorphic Epithelioid Diffuse Malignant Pleural Mesothelioma
Clinicopathologic Characteristics and Outcomes of Patients with Anaplastic Lymphoma Kinase-Positive Advanced Pulmonary Adenocarcinoma
Improved Survival after Pulmonary Metastasectomy for Soft Tissue Sarcoma
Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer
Phase II Study of Pemetrexed and Cisplatin, with Chest Radiotherapy Followed by Docetaxel in Patients with Stage III Non-small Cell Lung Cancer
Population-Based Estimates of Survival Benefit Associated with Combined Modality Therapy in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer
Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification
EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery
Phase I Study of Sunitinib and Erlotinib in Advanced Nonsquamous Non-small Cell Lung Cancer
Palmar Bullous Blistering Induced by Erlotinib
Clinical Relevance of Autoantibody Detection in Lung Cancer
Complete Radiological Response of Metastatic Anaplastic Lymphoma Kinase-Positive Signet Ring Lung Adenocarcinoma to Systemic Chemotherapy
Isolated Epithelioid Trophoblastic Tumor Mimicking Non-small Cell Lung Cancer
Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer
Angiosarcoma Arising from Right Atrium
Chemotherapy Dose Intensity and Survival in Non-small Cell Lung Cancer
Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma
How Do We Do It?